Developing Vaccines to Target Cancer's Blood Vessels

The video discusses a vaccine that stimulates the immune system to attack cancer by targeting both the tumor and its blood supply. The challenge lies in the tumor's genetic similarity to normal cells, which the immune system typically does not attack. The vaccine employs a dual approach: encouraging the immune system to recognize cancer as an infection and countering the blood supply increase to tumors. While not a universal solution, the vaccine could benefit 20% of patients with major solid cancers.

How does the vaccine encourage the immune system to recognize cancer?

What percentage of patients with major solid cancers is the vaccine expected to help?